ORIC Pharmaceuticals, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ANEB
Anebulo Pharmaceuticals, Inc. |
$1.62 | $56.28 M | -5.86 | 2 | $0 |
ANTX
AN2 Therapeutics, Inc. |
$1.36 | $60.55 M | -0.81 | 41 | $0 |
CCCC
C4 Therapeutics, Inc. |
$3.87 | $320.64 M | -1.97 | 145 | $20.76 M |
CELC
Celcuity Inc. |
$12.53 | $501.59 M | -5.14 | 55 | $0 |
CGEM
Cullinan Oncology, Inc. |
$12.27 | $1.29 B | -7.16 | 85 | $0 |
DBTX
Decibel Therapeutics, Inc. |
$4.91 | $123.37 M | -1.93 | 68 | $0 |
ELVN
Enliven Therapeutics, Inc. |
$23.15 | $984.95 M | -11.97 | 46 | $0 |
EWTX
Edgewise Therapeutics, Inc. |
$29.62 | $1.65 B | -11.47 | 108 | $0 |
HOWL
Werewolf Therapeutics, Inc. |
$1.54 | $151.66 M | -3.17 | 45 | $19.94 M |
IMRX
Immuneering Corporation |
$2.25 | $40.63 M | -0.74 | 66 | $0 |
MLYS
Mineralys Therapeutics, Inc. |
$12.80 | $652.38 M | -6.03 | 28 | $0 |
MOLN
Molecular Partners AG |
$5.31 | $135.05 M | -2.03 | 167 | $7.04 M |
PEPG
PepGen Inc. |
$4.03 | $537.15 M | -5.11 | 76 | $0 |
PHVS
Pharvaris N.V. |
$18.83 | $843.31 M | -5.8 | 83 | $0 |
PMVP
PMV Pharmaceuticals, Inc. |
$1.47 | $85.40 M | -1.26 | 63 | $0 |
SEER
Seer, Inc. |
$2.21 | $112.34 M | -1.34 | 147 | $15.18 M |
THRX
Theseus Pharmaceuticals, Inc. |
$4.07 | $181.50 M | -3.03 | 38 | $0 |